The Persian Gulf Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Persian Gulf Newswire.

Press releases published on June 3, 2026

Jun. 3, 2026

LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth

Indeterminate GlobeNewswire

Jun. 3, 2026

Odysight.ai to Participate in the 16th Annual ROTH London Conference on June 17 and 18

Indeterminate GlobeNewswire

Jun. 3, 2026

Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program

Indeterminate GlobeNewswire

Jun. 3, 2026

Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds

Indeterminate GlobeNewswire

Jun. 3, 2026

Rail Vision Technology Integrated into Railserve’s Commercially Launched Industrial Railyard Safety System

Indeterminate GlobeNewswire

Jun. 3, 2026

Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis

Indeterminate GlobeNewswire

Jun. 3, 2026

Terra Balcanica Obtains Exploration Licence in Bosnia-Herzegovina

Indeterminate GlobeNewswire

Jun. 3, 2026

RAID: Shadow Legends Launches ‘Web of Corruption’ Event

Indeterminate GlobeNewswire

Jun. 3, 2026

Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million

Indeterminate GlobeNewswire

Jun. 3, 2026

Koryx Copper Provides Project Development Update for the Haib Copper Project in Southern Namibia

Indeterminate GlobeNewswire

Jun. 3, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 3, 2026

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

Indeterminate GlobeNewswire

Jun. 3, 2026

Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer

Indeterminate GlobeNewswire

Jun. 3, 2026

Emerita Announces Appointments of New Independent Director and Corporate Secretary

Indeterminate GlobeNewswire

Jun. 3, 2026

Highland Copper Identifies Key Optimization Opportunities Through Detailed Engineering at the Copperwood Project

Indeterminate GlobeNewswire

Jun. 3, 2026

Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Jun. 3, 2026

Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms

Indeterminate GlobeNewswire

Jun. 3, 2026

Dark Horse Consulting Group and Altruist Biologics Announce Memorandum of Understanding to Advance Biologics Manufacturing and Development in China

Indeterminate GlobeNewswire

Jun. 3, 2026

Medicenna’s MDNA11 Potential in Earlier Line Melanoma Setting Highlighted in Presentation of the NEO-CYT trial at ASCO 2026

Indeterminate GlobeNewswire

Jun. 3, 2026

A.I.S. Resources Announces Grant of Options

Indeterminate GlobeNewswire